Hartig Drug Company has announced the addition of Nefense® nasal care products to its shelves at select locations in Iowa, Illinois, and Wisconsin. This expansion provides customers with new drug-free options for daily nasal hygiene, catering to a growing demand for non-medicated alternatives.
The Nefense lineup includes hypochlorous acid nasal sprays designed for adults, children, and infants, as well as a xylitol-based spray. These products offer a non-medicated approach to nasal care, potentially serving as alternatives to traditional decongestants. The availability of age-specific formulations ensures that families can find suitable options for all members, from the youngest to adults.
Published randomized clinical research has evaluated the efficacy of low-concentration hypochlorous acid nasal irrigation for chronic sinonasal symptoms and allergic rhinitis. Although these studies do not test Nefense-branded products directly, they provide scientific context supporting the potential benefits of the active ingredient. This research may reassure customers seeking evidence-based options.
Hartig Drug, a family-owned pharmacy and retail company founded in Dubuque, Iowa, in 1904, continues to serve communities across Iowa, Illinois, and Wisconsin. The addition of Nefense products aligns with the company's commitment to providing health, wellness, and everyday consumer products with personalized service.
Nefense, based in Dubuque, Iowa, focuses on daily nasal hygiene, airway care, and better breathing. Developed under the direction of Richard Downs, DDS, the portfolio includes HypoNasal, HypoNasal Junior, HypoBaby, and XyloClean. These products utilize hypochlorous acid and xylitol-based formulations designed for routine nasal care.
This move by Hartig Drug reflects a broader trend in retail pharmacy toward offering more natural and drug-free health solutions. By making these products available, Hartig Drug is responding to consumer preferences for alternatives that may have fewer side effects. For customers in the affected regions, the availability of Nefense products at Hartig Drug stores provides convenient access to these innovative nasal care options.
The decision to stock Nefense products is likely to impact the local market, giving customers more choices and potentially influencing other retailers to follow suit. As the demand for non-pharmaceutical interventions continues to rise, partnerships like this between regional pharmacies and specialized wellness brands may become more common.
For more information about Hartig Drug and its offerings, visit Hartig Drug. To learn more about Nefense and its products, visit Nefense.
